newsfilter
← Latest News
FDA Approved Drugs·

Approval of OXDERYS, NDA #221093 (Type 5 - New Formulation or New Manufacturer)

Approval Date: 11/09/2026 Drug Name: OXDERYS, NDA #221093 Submission: ORIG-1 Active Ingredients: DOXORUBICIN HYDROCHLORIDE Company: AVYXA HOLDINGS Submission Status: Approval Submission Classification: Type 5 - New Formulation or New Manufacturer Application Number: 221093

Company
AVYXA HOLDINGS
Keywords
DOXORUBICIN HYDROCHLORIDE